Merrimack, NeuroBo top healthcare gainers; Athersys, Emergent among losers

Nov. 09, 2022 10:02 AM ETVCEL, EBS, ATHX, NRBO, MACK, KALA, HCAT, OM, GDRX, LFSTBy: Ravikash, SA News Editor

stock market

hxdbzxy/iStock via Getty Images

  • Gainers: Merrimack Pharmaceuticals (MACK) +201%. NeuroBo Pharmaceuticals (NRBO) +45%. Kala Pharmaceuticals (KALA) +38%. Outset Medical (OM) +38%. Health Catalyst (HCAT) +27%.
  • Losers: Athersys (ATHX) -52%. Emergent BioSolutions (EBS) -32%. GoodRx (GDRX) -22%. Vericel (VCEL) -18%. LifeStance Health (LFST) -13%.

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.